Company intelligence / Profile preview

GI Biome Co., Ltd.

Ownership: Private
Development stage: Phase 1

Overview

GI Biome Co., Ltd. develops synbiotic-based therapies targeting the human gut microbiota to treat a range of chronic and incurable diseases. The company collaborates with leading academic institutions for new drug development. It has at least two programs in clinical trials focused on innovative approaches combining probiotics/prebiotics with other modalities for conditions like solid tumors, NAFLD/NASH, and Crohn’s disease. No published late-stage or commercial results yet.[1][2]

Therapeutic areas: OtherGastroenterology
Modalities: Synbiotics (combination of probiotics and prebiotics)microbiome-based therapies[2]
Industry: Biotech

Drug pipeline

6 assets

GB104

5 more assets in the full pipeline.

Request access →

Partnerships

Yonsei University Medical School Severance Hospital – joint research MOU for new drug development integrating protein drugs, antibody drugs, cell therapy by group companies including GI Innovation/GI Cell/GI Biome[2].

Beyond the preview

Go deeper on GI Biome Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GI Biome Co., Ltd..

Explore the full profile